Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome.
D000818:Animals; D001971:Bromocriptine / Q000378:metabolism / Q000627:therapeutic use*; D002230:Carbidopa / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004876:Ergot Alkaloids / Q000494:pharmacology; D000882:Haplorhini; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects
D004876:Ergot Alkaloids; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine; D001971:Bromocriptine; D007980:Levodopa; D002230:Carbidopa